Skip to main content

Peer Review reports

From: Synthesis of novel mono- and bis-pyrazolylthiazole derivatives as anti-liver cancer agents through EGFR/HER2 target inhibition

Original Submission
19 Nov 2022 Submitted Original manuscript
25 Nov 2022 Author responded Author comments - Kamal M. Dawood
6 Dec 2022 Reviewed Reviewer Report
13 Dec 2022 Reviewed Reviewer Report
12 Jan 2023 Reviewed Reviewer Report - Shailee V. Tiwari
23 Jan 2023 Author responded Author comments - Kamal M. Dawood
Resubmission - Version 2
25 Nov 2022 Submitted Manuscript version 2
25 Jan 2023 Author responded Author comments - Kamal M. Dawood
Resubmission - Version 3
25 Jan 2023 Submitted Manuscript version 3
25 Jan 2023 Author responded Author comments - Kamal M. Dawood
Resubmission - Version 4
25 Jan 2023 Submitted Manuscript version 4
4 Feb 2023 Reviewed Reviewer Report
6 Feb 2023 Reviewed Reviewer Report
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
23 Feb 2023 Editorially accepted
8 Jun 2023 Article published 10.1186/s13065-023-00921-6

You can find further information about peer review here.

Back to article page